India's Aarti Drugs gains after getting US FDA inspection report

Aarti Drugs

30/07/2024 06:44

** Shares of Aarti Drugs  ADRG.NS  gain ~2% to 512.55 rupees
    ** Drugmaker said US FDA concluded inspection at ADRG's
manufacturing facility in Himachal Pradesh
    ** ADRG received establishment inspection report after
conclusion of inspection
    ** Stock up ~5% YTD, set for second straight annual gain 
    

 (Reporting by Kashish Tandon in Bengaluru)
 ((kashish.tandon@thomsonreuters.com))